Rights issue in Infant Bacterial Therapeutics AB (SE) — SEK 100 million Healthcare Rights issue in Infant Bacterial Therapeutics AB (SE) — SEK 100 million
Rights issue in Q-linea AB (SE) — SEK 263 million Healthcare Rights issue in Q-linea AB (SE) — SEK 263 million
Sale of MyMoney Europe AB (SE) to Sambla Group AB (SE) – Amount not disclosed FIG Sale of MyMoney Europe AB (SE) to Sambla Group AB (SE) – Amount not disclosed
Placing of shares in Beijer Ref AB (SE) — SEK 5.6 billion Business Services Placing of shares in Beijer Ref AB (SE) — SEK 5.6 billion
Rights issue in Starbreeze AB (SE) — SEK 453 million TMT Rights issue in Starbreeze AB (SE) — SEK 453 million
Recommended public offer to the shareholders of Serneke Group AB (SE) — SEK 1,020 million Real Estate Recommended public offer to the shareholders of Serneke Group AB (SE) — SEK 1,020 million
Senior unsecured bonds by Storskogen Group AB – SEK 2,000 million Industrials Senior unsecured bonds by Storskogen Group AB – SEK 2,000 million
Rights issue in BergenBio ASA (NO) — NOK 250 million Healthcare Rights issue in BergenBio ASA (NO) — NOK 250 million
Rights issue in Ferroamp AB (SE) — SEK 220 million Cleantech, Renewables & Infrastructure Rights issue in Ferroamp AB (SE) — SEK 220 million
Tier 2 bonds by NOBA Bank Group AB (SE) – NOK 400.5 million / SEK 351 million FIG Tier 2 bonds by NOBA Bank Group AB (SE) – NOK 400.5 million / SEK 351 million
Directed share issue in Vicore Pharma Holding AB (SE) — SEK 500 million Healthcare Directed share issue in Vicore Pharma Holding AB (SE) — SEK 500 million
Rights issue in Intervacc AB (SE) — SEK 104 million Healthcare Rights issue in Intervacc AB (SE) — SEK 104 million